Danielle Guerrieri
Family · Fredericktown, PANPI 1053839282
Payments from drug & device makers
Across 135 payments — averaging $17.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$505
- Lilly USA, LLC$385
- Novo Nordisk$341
- Exact Sciences$142
- Astellas Pharma US Inc$114
- Bayer$100
- plus $730 from 17 others
What the payments were for
- Food & beverage$2,317100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 30 | $505 |
| Lilly USA, LLC | 25 | $385 |
| Novo Nordisk | 18 | $341 |
| Exact Sciences | 7 | $142 |
| Astellas Pharma US Inc | 5 | $114 |
| Bayer | 7 | $100 |
| Merck | 5 | $92 |
| Amgen | 6 | $88 |
| Abbott | 5 | $77 |
| AbbVie | 4 | $74 |
| GSK | 4 | $72 |
| Boehringer Ingelheim | 3 | $48 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $46 |
| Edwards Lifesciences | 2 | $42 |
| Sanofi Pasteur Inc. | 2 | $38 |
| Shield Therapeutics Inc | 2 | $34 |
| Insulet Corporation | 1 | $21 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Organon | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Phadia US Inc. | 1 | $17 |
| Dexcom, Inc. | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $11 |
How this compares
$2,317 in reported general payments places this provider in the 85th percentile of 4,717 family providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 144 | $117,496 |
| JardianceEmpagliflozin | 83 | $80,408 |
| OzempicSemaglutide | 53 | $48,702 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 57 | $38,337 |
| MounjaroTirzepatide | 32 | $32,943 |
| TrulicityDulaglutide | 16 | $18,717 |
| RybelsusSemaglutide | 14 | $18,656 |
| JanuviaSitagliptin Phosphate | 17 | $17,421 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 30 | $14,222 |
| Spiriva RespimatTiotropium Bromide | 18 | $11,790 |
| EntrestoSacubitril/Valsartan | 17 | $11,463 |
| Enoxaparin Sodium | 12 | $11,187 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 62 | $10,276 |
| LinzessLinaclotide | 13 | $9,224 |
| Breo ElliptaFluticasone/Vilanterol | 20 | $8,182 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Lyrica | $505 | $124,549156 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $48 | $92,199101 claims |
| Novo NordiskOzempic, Rybelsus | $341 | $67,35867 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $72 | $60,742107 claims |
| Lilly USA, LLCMounjaro, Trulicity | $385 | $51,66048 claims |
| MerckJanuvia | $92 | $17,42117 claims |
| AbbVieLinzess, Synthroid | $74 | $11,47643 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,717 family providers in Pennsylvania.
Other family in Fredericktown
- Kathleen ScholzPittsburgh$397K
- Shannon FitzgeraldAllison Park$370K
- Stephanie HarshbargerCamp Hill$317K
- Whitney BowlesFort Washington$253K
- Kweilynn GreenePittsburgh$139K
- Jessica LindenbergerPittsburgh$131K
- Kami NestlerWilkes Barre$129K
- Bethany ThomasPhiladelphia$126K
- Margaret RosenzweigPittsburgh$89K
- Amanda GrippoDickson Cty$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.